Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04926831
Title Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC (Geometry-N)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Capmatinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Oncology Hematology Recruiting La Jolla California 92037 United States Details
University of California Davis Cancer Center Recruiting Sacramento California 95817 United States Details
Dana Farber Cancer Center Recruiting Boston Massachusetts 02215 United States Details
University of Michigan Health System Recruiting Ann Arbor Michigan 48109-0391 United States Details
Memorial Sloan Kettering Recruiting New York New York 10017 United States Details
Irving Pavilion; Diabetes Research Unit Recruiting New York New York 10032-3784 United States Details
University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Fairfax-Northern Virginia Hematology-Oncology Recruiting Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field